125 related articles for article (PubMed ID: 18282234)
21. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
22. Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide.
Porceddu SV; Sidhom M; Foote M; Burmeister E; Stoneley A; El Hawwari B; Milross C; Kenny L; Poulsen M; Coman WB
J Med Imaging Radiat Oncol; 2008 Oct; 52(5):491-6. PubMed ID: 19032396
[TBL] [Abstract][Full Text] [Related]
23. Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
[TBL] [Abstract][Full Text] [Related]
24. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
25. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts.
Ksiazkiewicz M; Gottfried E; Kreutz M; Mack M; Hofstaedter F; Kunz-Schughart LA
Immunobiology; 2010; 215(9-10):737-47. PubMed ID: 20605053
[TBL] [Abstract][Full Text] [Related]
26. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
[TBL] [Abstract][Full Text] [Related]
27. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.
Rickman DS; Millon R; De Reynies A; Thomas E; Wasylyk C; Muller D; Abecassis J; Wasylyk B
Oncogene; 2008 Nov; 27(51):6607-22. PubMed ID: 18679425
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue.
Silzle T; Kreutz M; Dobler MA; Brockhoff G; Knuechel R; Kunz-Schughart LA
Eur J Immunol; 2003 May; 33(5):1311-20. PubMed ID: 12731056
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes.
Schmidtner J; Distel LV; Ott OJ; Nkenke E; Sprung CN; Fietkau R; Lubgan D
Int J Hyperthermia; 2009 Aug; 25(5):347-54. PubMed ID: 19479600
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo interleukin (IL)-1 beta, IL-6, IL-12 and tumor necrosis factor-alpha responsiveness with monocytes from patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Eur Arch Otorhinolaryngol; 1999; 256(5):250-6. PubMed ID: 10392301
[TBL] [Abstract][Full Text] [Related]
32. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
[TBL] [Abstract][Full Text] [Related]
33. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
34. IL-1beta as a determinant in silica-induced cytokine responses in monocyte-endothelial cell co-cultures.
Herseth J; Refsnes M; Låg M; Hetland G; Schwarze P
Hum Exp Toxicol; 2008 May; 27(5):387-99. PubMed ID: 18715885
[TBL] [Abstract][Full Text] [Related]
35. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.
Lam-ubol A; Hopkin D; Letuchy EM; Kurago ZB
Inflammation; 2010 Aug; 33(4):207-23. PubMed ID: 20084448
[TBL] [Abstract][Full Text] [Related]
36. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
37. Tumor-stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells.
Koontongkaew S; Amornphimoltham P; Yapong B
Cell Biol Int; 2009 Feb; 33(2):165-73. PubMed ID: 18996211
[TBL] [Abstract][Full Text] [Related]
38. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation.
Konur A; Kreutz M; Knüchel R; Krause SW; Andreesen R
Int J Cancer; 1996 May; 66(5):645-52. PubMed ID: 8647627
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
